Source: HEXO.

HEXO Corp. (TSX:HEXO) slid 2.0 per cent since a sobering report about its place in the cannabis industry. Brokerage ATB highlighted appreciable liquidity, dilution, and going-concern dangers for the pot stock and its inventory.

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Top Story: Xebra Brands (CSE:XBRA) lists at Alberta Gaming and Liquor Commission and launches “NEO”

2 | City View Green (CSE:CVGR) closes second and final tranche of non-brokered private placement

3 | New Leaf Ventures (CSE:NLV) signs genetics supply agreement

4 | Innocan Pharma (CSE:INNO) to launch CBD veterinary commercialization team

Top Cannabis Stocks Mar 17 to Mar 23, 2023

1. T.HEXO | 10,894 views | HEXO Corp.
2. T.WEED | 5,742 views | Canopy Growth Corp.
3. TLRY | 4,676 views | Tilray Brands Inc.
4. T.TBP | 1,779 views | Tetra BioPharma
5. T.ACB | 1,711 views | Aurora Cannabis Inc.
6. C.TNY | 1,649 views | Tinley Beverage Co.

More From The Market Online

This AI stock is disrupting the event tickets monopoly

The global event tickets market will approach US$100 billion by 2030 but remains in need of disruptors to dethrone high-fee market leaders.

@ the Bell: TSX follows global downward trend

Falling metal prices brought down mining and energy shares, and the tech sector was the only gainer on the TSX.

The Market Online’s Weekly Cannabis Report – June 21, 2024

A Canadian cannabis pharmaceutical stock, has signed a licensing agreement with Remidose Aerosols to acquire its metered dose inhaler.

MediPharm bolsters revenue with new medical cannabis products

MediPharm Labs (TSX:LABS), a cannabis pharmaceutical stock, increases revenue through a new licensing agreement with Remidose Aerosols.